We provide integrated media products and manufacturing solutions for regenerative medicine — bridging research-grade materials and clinical-grade manufacturing. From chemically defined media to GMP-ready supply, we help your therapy move forward with confidence.
Our Commitment to Regenerative Medicine
Integrated media products and manufacturing solutions for regenerative medicine — bridging research materials to clinical-grade manufacturing.
Customization
Tailored to your cells and process. A modular design enables fast matching and optimization.
Reliability
Simplified supply, stable results. GMP-grade production delivers consistency and reduces material burden.
Safety
Built for clinical applications. Made with animal-origin-free raw materials and low endotoxin to support IND/DMF use.
Risk Control
A traceable, audit-ready supply chain. Regional production and local inventory reduce import risk and support supply continuity.
From Research to Clinic — One Translational Platform
We support your program at every stage — from research-grade catalog products, through RUO-to-GMP transition, to clinical-grade GMP solutions.
Research & Development — Catalog Products
– Media & Reagents (RUO)
– Cryopreservation Solutions & Equipment
– Serum & Serum-free Solutions
– Buffer & Sterile Water
– Biologicals
Preclinical Development — RUO-to-GMP Transition
– Specification & Process Setup
– Material & Supplier Qualification
– Analytical & Release Criteria
– Stability & Compatibility
– Regulatory Documentation
Clinical Development (Phase 1–3) — Clinical Solution (GMP)
GMP manufacturing in accordance with EU Annex 1, at excipient level.
Commercialization
Scale-up to commercial supply.
A structured four-step workflow
Chemically defined formulations built around basal media, growth factors, and small molecules — bridging research-grade to GMP-ready manufacturing.
1. Design
Begin with five foundational basal media panels, tailored to your cell type and application.
2. Screening
Two to three rounds of performance testing for viability, growth, and function.
3. Refine
Components systematically optimized for formulation precision and consistency.
4. Finalize
Optimal formulation confirmed and locked for scalable, traceable GMP transition.
A quality framework across three core areas
Developed in accordance with ICH Guideline Q2 — supporting a traceable, compliance-ready pathway from cell identity to release testing.
Cell Identity
Phenotype & authentication
- Flow cytometry — phenotype & surface markers
- CAR antigen detection
- T / NK cell panels
- Activation & exhaustion status
- STR profiling — cell line authentication
Cell Characterization
Function & performance
- MSC differentiation — osteogenic, adipogenic, chondrogenic
- Immunomodulatory function — IDO, IL-6, IL-10, TGF-β
- Immunogenicity — cytotoxicity & cytokine release
- Growth performance — PDT, growth rate, viability
Safety & Process Control
Microbial safety & residuals
- Sterility
- Endotoxin
- Mycoplasma
- Virus screening
- Residual testing — FBS, antibiotics, TrypLE, etc.
Cell Expansion Media
Serum-free, chemically defined media designed for immune and stem cell expansion — engineered for performance, consistency, and a smooth path to clinical manufacturing.
Series line-up
NK / T cell–specific medium (serum-free, chemically defined) / MSC 3D medium (UCMSC) / Customized medium development
CMP® T-Expand
Robust T cell expansion, clinic-ready by design.
Key features
- Chemically defined and serum-free
- Expands T cells directly from PBMCs — no beads, no sorter required
- cGMP-compliant manufacture
- DMF-ready by 2026
Performance data
- Robust expansion of up to 638-fold, with >90% viability maintained throughout the 14-day process.
- High purity (CD3⁺: 91.5%, CD8⁺: 70.4%) with desirable phenotype retention, including 38% central memory T cells (TCM) on Day 14
Cryopreservation
Chemically defined, DMSO-free cryopreservation solutions that protect viability and preserve cell function across diverse cell types.
Series line-up
Cell Freezing Medium (DMSO-free, chemically defined) / Cryogenic Vials
CMP® CryoImmune
DMSO-free cryopreservation built for T and NK cells, preserving viability and near-complete recovery after thaw.
Key features
- Chemically defined and DMSO-free
- High viability with maintained cell function
- Applicable to diverse cell types
- cGMP-compliant manufacture
- DMF-ready by 2026
Performance data
- T cells: 72.3% viability and 99.8% recovery post-thaw.
- NK cells: 92.5% viability after cryopreservation.
CMP® CryoStem
DMSO-free cryopreservation that keeps MSCs viable, functional, and ready to expand right after thaw.
Key features
- Chemically defined and DMSO-free
- High viability with maintained cell function
- Applicable to diverse cell types
- cGMP-compliant manufacture
- DMF-ready by 2026
Performance data
- MSC viability >92% post-thaw, with 3.5× expansion in 96 hours and a doubling time of 28–35 hours.
- Post-thaw MSC marker profile: >98% CD73⁺, CD90⁺, CD105⁺.
Contact Us
Connect with CREATIVE LIFE SCIENCE
Explore partnership opportunities, technical support, and advanced biomanufacturing solutions with our team.